أفضل بودكاسات Adis (2024)

1
A Podcast on Platinum Eligibility and Treatment Sequencing in Platinum-Eligible Patients with Locally Advanced or Metastatic Urothelial Carcinoma 48:30

3d ago48:30

48:30

In this podcast, Shilpa Gupta from the Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, Helen H.-S. Moon from the Kaiser Permanente Riverside Medical Center, Riverside, CA, and Srikala S. Sridhar from the Princess Margaret Cancer Centre, University Health Network, Toronto, Canada discus recent developments in the treatment landscape for ad…

1
Podcast on the IWGDF 2023 Guidelines on the Prevention of Foot Ulcers in Persons with Diabetes 7:51

2M ago7:51

7:51

In this podcast, the Chair and Secretary of the 2023 International Working Group on the Diabetic Foot (IWGDF) guideline on prevention for diabetes-related foot ulcers. This podcast aims to highlight the importance of ulcer prevention and the opportunities to incorporate recommendations into clinical practice. This podcast is published open access i…

1
Podcast on Emerging Treatment Options for Pediatric Patients with ALK-Positive Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumors 23:28

2M ago23:28

23:28

Anaplastic large cell lymphoma (ALCL) and inflammatory myofibroblastic tumor (IMT) are rare cancers observed predominantly in children and young adults. ALCL accounts for 10–15% of all pediatric non-Hodgkin lymphomas and is commonly diagnosed at an advanced stage of disease. This podcast provides an overview of ALK-positive ALCL and IMT. The author…

1
Real-World Data on Therapies for Relapsed or Refractory Multiple Myeloma: Key Data from ASH 2023—A Podcast 33:55

2M ago33:55

33:55

In this podcast, the authors reviewed and discussed seven abstracts presented at the 65th Annual Meeting of the American Society of Hematology, focusing on B cell maturation antigen-directed therapies, emphasizing the value of real-world data (RWD) in treatment decision-making, and suggesting how RWD can help advance multiple myeloma research. Thes…

1
Identification of a Patient Suitable for CAR-T Cell Therapy in the Outpatient Setting: A Vodcast and Case Example 21:31

2M ago21:31

21:31

Chimeric antigen receptor T cell (CAR-T) therapies targeting the CD19 antigen have been associated with high and durable response rates in patients with diffuse large B cell lymphoma (DLBCL). In this podcast, Dr. Foley and Dr. Kuruvilla discuss the case of a patient presenting with the ideal profile for CAR-T cell therapy referral whilst also deter…

1
The Importance of Biomarker Testing in the Treatment of Advanced Non-Small Cell Lung Cancer: A Podcast 32:07

3M ago32:07

32:07

Panel-based sequencing platforms are becoming more accessible, and molecular biomarker analysis of circulating tumor DNA is becoming more common. In this podcast, authors discuss the importance of biomarker testing in advanced non-small cell lung cancer (NSCLC) and explore topics such as testing methodologies, effect of biomarker testing on patient…

1
The Why, What and Where Podcast on the Updated 2023 IWGDF Guideline on Offloading Treatments for Diabetes-Related Foot Ulcers 9:47

3M ago9:47

9:47

In this podcast the Chair and Secretary of the 2023 International Working Group on the Diabetic Foot (IWGDF) guideline on offloading treatments for diabetes-related foot ulcers briefly discuss why we need offloading treatments for people with diabetes-related foot ulcers, what the new international offloading guideline recommends, and where offload…

1
Podcast on How to Classify Foot Ulcers in People with Diabetes (2023 Update of the IWGDF Guidelines on Classification) 12:47

4M ago12:47

12:47

In this podcast, the Chair and Secretary of the 2023 update of the International Working Group of the Diabetic Foot (IWGDF) guidelines on Classification discuss the results of update to the guidelines addressing the use of systems to classify foot ulcers in people with diabetes in routine clinical practice. This podcast is published open access in …

1
Current and Emerging Treatment Options for Patients with Metastatic EGFR-Mutated Non-small Cell Lung Cancer After Progression on Osimertinib and Platinum-Based Chemotherapy: A Podcast Discussion 30:15

4M ago30:15

30:15

Patients with metastatic epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) are widely treated with osimertinib, the preferred first-line treatment option. However, disease progression inevitably occurs, driven by EGFR-dependent or EGFR-independent mechanisms of resistance. Platinum-based chemotherapy is the recommen…

1
Shared Decision-Making on Using a CDK4/6 Inhibitor plus an Aromatase Inhibitor for HR+/HER2− Metastatic Breast Cancer: A Podcast 15:26

4M ago15:26

15:26

In this podcast, authors discuss how to ensure that individual patients’ needs and concerns are addressed when it comes to shared decision-making on treatment for metastatic breast cancer. Including an overview of different approaches for initial consultations, strategies for tailoring conversations based on a patient’s background or health literac…

1
The Evolving Role of PD-(L)1 Inhibition in Optimizing Outcomes for High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC): A Podcast 35:25

4M ago35:25

35:25

Authors Dr Peter Black and Dr Bernie Eigl aim to provide an overview of the non-muscle-invasive bladder cancer (NMIBC) landscape with a focus on high-risk NMIBC. This includes understanding the diagnosis and current treatment approaches with a focus on the medical needs and high-risk NMIBC treatment, highlighting the potential challenges associated…

1
A Podcast on Pre- or Perioperative Chemoimmunotherapy for Stage III Non-Small Cell Lung Cancer: Shared Agreement from the Thoracic Surgeon and Oncologist Perspectives 26:33

4M ago26:33

26:33

In this podcast, authors Dr Luca Bertolaccini and Dr Giulio Metro touch upon the need for a standard definition of resectability in patients with resectable stage III non-small cell lung cancer (NSCLC). This podcast gives the perspectives of a thoracic surgeon and an oncologist, and suggests a shared agreement between two of the main actors involve…

1
Optimizing Real-World Outcomes in High-Risk Relapsed/Refractory (r/r) FL with CAR-T Cell Therapy: A Vodcast and Case Example 10:35

4M ago10:35

10:35

In this podcast, author Dr Kai Hübel discussed a case of a patient with high-risk relapse follicular lymphoma. This discussion outlines the potential effectiveness of chimeric antigen receptor (CAR)-T cell therapy in relapsed/refractory follicular lymphoma. This podcast is adapted from a vodcast article published open access in Oncology and Therapy…

1
Inotuzumab in Older Patients with Newly Diagnosed Acute Lymphoblastic Leukemia — A Podcast 34:33

4M ago34:33

34:33

In this podcast, Elias Jabbour from the University of Texas MD Anderson Cancer Center, Houston, TX, and Matthias Stelljes from the Universitätsklinikum Münster, Münster, Germany summarize and highlight some of the recent findings on the use of inotuzumab ozogamicin as induction therapy for older adults with newly diagnosed acute lymphoblastic leuke…

1
A Patient-Centered Approach to Vernal Keratoconjunctivitis (VKC): A Podcast 35:09

4M ago35:09

35:09

This podcast is published open access in Ophthalmology and Therapy and is fully citeable. You can access the original published podcast article through the Ophthalmology and Therapy website and by using this link. All conflicts of interest can be found online. Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4…

1
Cross-speciality Perspectives on Practical Management of Atopic Dermatitis-Associated Ocular Surface Diseases 21:28

5M ago21:28

21:28

This podcast is published open access in Dermatology and Therapy and is fully citeable. You can access the original published podcast article through the Dermatology and Therapy website and by using this link: https://link.springer.com/article/10.1007/s13555-023-01093-w. All conflicts of interest can be found online. Open Access This podcast is lic…

1
A Podcast on the Use of CGM in Optimizing Type 2 Diabetes Management with Non-intensive Insulin Treatment in the Primary Care Setting 27:33

6M ago27:33

27:33

In this podcast, we are joined by Professor Sam Seidu who discusses the potential of continuous glucose monitoring (CGM) in managing type 2 diabetes with non-intensive insulin treatment in primary care. This includes a discussion on the evidence for CGM use, the role of primary healthcare in diabetes management, and some practical tips for interpre…

1
Podcast: Influenza-Associated Complications and the Impact of Vaccination on Public Health 22:09

8M ago22:09

22:09

This podcast is published open access in Infectious Diseases and Therapy and is fully citeable. You can access the original published podcast article through the Infectious Diseases and Therapy website and by using this link: https://link.springer.com/article/10.1007/s40121-023-00885-z. All conflicts of interest can be found online. Open Access Thi…

1
Podcast on Identifying and Understanding Barriers to Care in Undeserved Populations With MS in the United States 16:41

8M ago16:41

16:41

This podcast is published open access in Neurology and Therapy and is fully citeable. You can access the original published podcast article through the Neurology and Therapy website and by using this link: Podcast on Identifying and Understanding Barriers to Care in Underserved Populations With MS in the United States | Neurology and Therapy (sprin…

1
Podcast on Self-administered Intranasal Etripamil for Symptomatic Paroxysmal Supraventricular Tachycardia: The RAPID Trial 27:31

8M ago27:31

27:31

In this podcast, Dr Lip and Dr Stambler discuss the RAPID trial (NCT03464019), which was a phase 3 study that evaluated the safety and efficacy of etripamil in terminating PSVT episodes using a repeat-dosing regimen. RAPID was a multicenter, randomized trial that enrolled adults with electrocardiograph (ECG)-documented PSVT episodes lasting ≥ 20 mi…

1
EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast 41:35

9M ago41:35

41:35

In this podcast, Xiuning Le from the University of Texas MD Anderson Cancer Center, Houston, TX, Eric Nadler from the Baylor University Medical Center, Dallas, TX, Daniel Costa from the Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, and John Heymach from the University of Texas MD Anderson Cancer Center, Houston, TX discu…

1
Biomarker Testing for Actionable Alterations in NSCLC—Perspectives from US-Based Academic and Community Oncologists: A Podcast 33:23

9M ago33:23

33:23

This podcast is published open access in Advances in Therapy and is fully citeable. You can access the original published podcast article through the Advances in Therapy website and by using this link: https://link.springer.com/article/10.1007/s12325-023-02664-1. All conflicts of interest can be found online. Open Access This podcast is licensed un…

1
Expert Discussion on Challenges in C3G Diagnosis: A Podcast Article on Best Practices in Kidney Biopsies 26:21

9M ago26:21

26:21

This podcast is published open access in Advances in Therapy and is fully citeable. You can access the original published podcast article through the Advances in Therapy website and by using this link: Expert Discussion on Challenges in C3G Diagnosis: A Podcast Article on Best Practices in Kidney Biopsies | Advances in Therapy (springer.com). All c…

1
EGFR Mutations Are Not All the Same: the Importance of Biomarker Testing in Non-small Cell Lung Cancer (NSCLC)—A Podcast Discussion Between Patients and Oncologists 47:34

9M ago47:34

47:34

In this podcast, two oncologists and two patient advocates from the patient advocacy group EGFR Resisters talk about the importance of biomarker testing for patients with non-small cell lung cancer and how this can affect treatment decisions and personalised medicine. The panel discusses what biomarkers are, the processes involved in obtaining biom…

1
Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy) 23:17

10M ago23:17

23:17

This podcast is published open access in Advances in Therapy and is fully citeable. You can access the original published podcast article through the Advances in Therapy website and by using this link: Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy) | …

1
Genetic Testing in Metastatic Breast Cancer in the USA: A Podcast 28:38

10M ago28:38

28:38

In this podcast, a healthcare professional discusses germline genetic testing with a patient advocate and answers questions regarding the importance of testing in patients with metastatic breast cancer, with a specific focus on germline or inherited breast cancer susceptibility gene (BRCA) mutations. In the USA, national guidelines recommend that a…

1
Podcast on Lorlatinib as a First-Line Treatment Option for Patients with ALK-Positive Metastatic NSCLC with Brain Metastasis 37:19

11M ago37:19

37:19

Brain metastases are especially common in anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC), with a cumulative incidence of over 50% and associated with a poor prognosis, high symptom burden, and decreased quality of life. In this podcast, authors discuss the clinical significance of controlling the onset of brain metasta…

1
First Line Medical Treatment of Metastatic Renal Cell Carcinoma: A Podcast on Choosing Wisely and Managing Safely 16:53

12M ago16:53

16:53

With recent advancements in medical treatments for metastatic renal cell carcinoma (mRCC), increased treatment efficiency may also come with increased toxicity. In this podcast, authors discuss the appropriate management of the adverse events that result from drug toxicity in order to achieve optimal oncological outcomes for their patients whilst s…

1
A Podcast Discussion on the Current Treatment Landscape for Renal Cell Carcinoma 26:21

12M ago26:21

26:21

This podcast covers the recent developments in the treatment of metastatic renal cell carcinoma (mRCC) and the ongoing phase 3 trials in this space. Whilst reflecting on these data, as well as the current ESMO guidelines, authors discuss how to choose the appropriate treatment for individualized treatment journeys for patients and talk through the …

1
How I Treat Chronic Inflammatory Demyelinating Polyneuropathy Podcast 27:24

1y ago27:24

27:24

This podcast is published open access in Neurology and Therapy and is fully citeable. You can access the original published podcast article through the Neurology and Therapy website and by using this link: How I Treat Chronic Inflammatory Demyelinating Polyneuropathy Podcast | SpringerLink All conflicts of interest can be found online. Open Access …

1
Podcast on the Challenges and Recommendations to Address Unmet Needs in MS for LGBTQ+ Populations in the United States 19:37

1y ago19:37

19:37

This podcast is published open access in NETH and is fully citeable. You can access the original published podcast article through the NETH website and by using this link: https://link.springer.com/article/10.1007/s40120-023-00506-4 All conflicts of interest can be found online. Open Access This podcast is licensed under a Creative Commons Attribut…

1
Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A Podcast 49:55

1y ago49:55

49:55

In this podcast, the authors summarize and highlight some of the T cell–redirecting bispecific antibodies (BsAb) currently in development for the treatment of relapsed/refractory multiple myeloma with a focus on the data reported at the oral session for BsAb at the American Society of Hematology’s 2022 meeting from clinical phase 1 and 2 studies. T…

1
Expert Perspectives on the Vaccination of Individuals Who Are at Increased Risk of Meningococcal Disease Due to Medical Conditions: A Podcast 22:40

1y ago22:40

22:40

In this podcast, experts discuss the challenges for implementing vaccine recommendations for individuals with medical conditions at increased risk of developing meningococcal disease. Strategies to increase vaccine coverage are also discussed. This podcast is published open access in Infectious Diseases and Therapy and is fully citeable. You can ac…

1
Patient and Healthcare Professional Perspectives from ESMO 2022 on Bladder and Kidney Cancer: A Podcast 31:15

1y ago31:15

31:15

In this plain language podcast, highlights from the European Society for Medical Oncology (ESMO) Congress are discussed for a second year in a row, from the perspective of both a patient advocate and a healthcare professional. Here, the authors discuss the importance of involving patients in the design of clinical trials, as well as strategies to i…

1
Podcast to Discuss Therapy Management for Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Axitinib Plus an Immune Checkpoint Inhibitor 31:40

1y ago31:40

31:40

This podcast covers topics including the metastatic renal cell carcinoma landscape with a focus on immune-oncology (IO) agents and tyrosine kinase inhibitors, axitinib indication (combination and monotherapy), a summary of efficacy and safety data, dose modification guidelines, and author experience of managing patients with the most common adverse…

1
P-REALITY X: A Real-World Analysis of Palbociclib Plus an Aromatase Inhibitor in HR+/HER2− Metastatic Breast Cancer—A Podcast 16:00

1y ago16:00

16:00

In this podcast, Adam Brufsky from the UPMC Hillman Cancer Center, Magee-Women’s Hospital, University of Pittsburgh Medical Center in Pittsburgh, and Christopher Gallagher from the Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC discuss how real-world data in heterogeneous patient populations can complement clinical …

1
HER2-Low Breast Cancer—Diagnostic Challenges and Opportunities for Insights from Ongoing Studies: A Podcast 28:16

1y ago28:16

28:16

In this podcast, Aditya Bardia from the Massachusetts General Hospital, Harvard Medical School in Boston, and Giuseppe Viale from the Department of Pathology and Laboratory Medicine at the European Institute of Oncology in Milan discuss HER2-low breast cancer, including the implications of the recent US FDA and EU approval of trastuzumab deruxtecan…

1
Podcast on the Art of the Patient Conversation: Healthcare Provider Perspectives to Improve Outcomes in Multiple Sclerosis 22:10

1+ y ago22:10

22:10

In this podcast article, nurse practitioners discuss multimodal strategies that enable appropriate conversations to meet patients’ needs through the following four techniques: patient-centric language, teach-back, open-ended questions, and active listening and paraphrasing. These techniques are incorporated into example patient–provider conversatio…

1
Living with Type 2 Diabetes: Podcast of a Patient–Physician Discussion 18:20

1+ y ago18:20

18:20

In this podcast, authors Pamela Kushner and Anne Dalin provide a patient and a clinician discussion on a lived experience of the diagnosis of type 2 diabetes, and the importance of patient education for understanding and managing type 2 diabetes and its complications. This podcast is published open access in Diabetes Therapy and is fully citeable. …

1
Current and Future Perspectives of Health-Related Quality of Life in Resectable EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC): A Podcast 39:09

1+ y ago39:09

39:09

In this podcast, Thomas John from the Department of Medical Oncology at the Peter MacCallum Cancer Centre in Melbourne, Margarita Majem from the Department of Medical Oncology at the Hospital de la Santa Creu i Sant Pau in Barcelona, Diane Legg, founder of LUNGSTRONG, and Jonathan Goldman from the David Geffen School of Medicine at the University o…

1
Diabetes Therapy Podcast: Real-World Data for Glucose Sensing Technologies in Type 1 Diabetes 27:27

1+ y ago27:27

27:27

This podcast with Nick Oliver from Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London discusses real-world data from glucose sensing technologies in type 1 diabetes. This podcast is published open access in Diabetes Therapy and is fully citeable. You can access the original published podcast article t…

1
Diabetes Therapy Podcast: Mind–Body Medicine in Diabetes Management 31:19

2y ago31:19

31:19

This podcast with Sanjay Kalra from Department of Endocrinology at Bharti Hospital and Vaishali Deshmukh from Deenanath Mangeshkar Hospital discuss Mind–Body Medicine in Diabetes Management. This podcast is published open access in Diabetes Therapy and is fully citeable. You can access the original published podcast article through the Diabetes The…

1
A Patient Perspective on Quality of Life with wAMD: A Podcast 27:27

2y ago27:27

27:27

This podcast is published open access in Ophthalmology and Therapy and is fully citeable. You can access the original published podcast article through the Ophthalmology and Therapy website and by using this link: https://link.springer.com/article/10.1007/s40123-022-00528-5. All conflicts of interest can be found online. Open Access This podcast is…

1
The FIDELIO Study Podcast 24:58

2+ y ago24:58

24:58

In this podcast, Robert Toto, Professor of Internal Medicine at the University of Texas Southwestern Medical Center and George Bakris, Professor of Medicine and Director of the American Heart Association Comprehensive Hypertension Center at the University of Chicago discuss the key findings from the FIDELIO study. This podcast is published open acc…

1
Aldosterone and Mineralocorticoid Receptor Antagonists in 2021: A Paradigm Shift 24:34

2+ y ago24:34

24:34

In this podcast, Dr Murray Epstein, Professor of Medicine Emeritus in the division of Nephrology and Hypertension at the University of Miami, Miller School of Medicine, discusses Aldosterone and Mineralocorticoid Receptor Antagonists in 2021. This podcast is published open access in Diabetes Therapy and is fully citeable. You can access the origina…

1
Patient and Healthcare Professional Perspectives from ESMO 2021 on Bladder and Kidney Cancer: A Podcast 27:58

2+ y ago27:58

27:58

In this plain language podcast, highlights from the European Society for Medical Oncology (ESMO) Congress 2021 are discussed from the perspective of both a patient and a healthcare professional by authors Alex Filicevas & Thomas B. Powles. Data from studies in bladder and kidney cancer offer new hope for patients; however, expectations in the patie…

1
Podcast on the Management of Adverse Events Associated with Lorlatinib 32:27

2+ y ago32:27

32:27

Here Dr Todd Bauer and Dr Erin Bertino cover some of the unmet needs in patients with anaplastic lymphoma kinase-positive lung cancer, the development of lorlatinib, and how it's being used in clinical practice. They also look at how to manage some of the common adverse events, particularly central nervous system toxicity and hyperlipidemia, that t…

1
Chronic Myeloid Leukemia Data at ASH 2021: A Podcast on Patient Unmet Needs and Later-Line Treatment Developments 14:42

2+ y ago14:42

14:42

Dr. Massimo Breccia from the Department of Translational and Precision Medicine at the University of Rome joins us to talk through the top highlights of the chronic myeloid leukemia data from the 2021 American Society of Hematology Conference. Here he gives specific focus to patient unmet needs and later-line therapies for the disease. This podcast…

1
Podcast on B Cell-Targeting Therapies and Other Multiple Sclerosis Concerns During COVID-19 28:31

2+ y ago28:31

28:31

Dr Robert K. Shin, Dr Pavle Repovic and Dr Joseph R. Berger discuss the topic of B cell-targeting therapies and other concerns for those living with multiple sclerosis during the COVID-19 pandemic. This podcast is published open access in Neurology and Therapy and is fully citeable. You can access the original published podcast article through the …

المدونة الصوتية تستحق الاستماع

Adis بودكاست

المدونة الصوتية تستحق الاستماع

دليل مرجعي سريع